ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO358

A Simplified Lung Ultrasound-Guided Management Protocol of Pulmonary Congestion in Hemodialysis

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Kaysi, Saleh, UVC Brugmann, Brussels, Belgium
  • Hamad, Abdullah Ibrahim, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
  • Taghavi, Maxime, UVC Brugmann, Brussels, Belgium
  • Ibrahim, Rania Abdelaziz, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
  • Ateya, Heba Mohamed, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
  • Mathew, Mincy, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
  • Alkadi, Mohamad M., Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
  • Al-Malki, Hassan A., Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
  • Nortier, Joelle L., UVC Brugmann, Brussels, Belgium
Background

Pulmonary congestion PC is frequent in Hemodialysis HD. We validated the first simplified LUS-guided PC management protocol in HD and evaluated its impact on blood pressure BP.

Methods

Prospective randomized multi-center trial: stable HD patients in 3 countries.
Randomized: active A and control C groups.
Bedside LUS after mid-week session at: Day 1, 15, 30, 45, 60.
LUS according to the 8-zone method. B line score BLS of > 5 represented significant PC.
Dry weight DW was adapted according to standard of care in the C group. In the A group, in addition, if BLS was > 5 at day 1 or 15 then DW was reduced by 500 g.
Home BP monitoring HBPM weekly.

Results

100 HD patients up until now. Age (60.5 ± 14.6) years, 60% diabetics.

In the A group, mean BLS at day 1 (13.5 ± 9) decreased (8.32 ± 6.8) at day 60. (P<0.001). Figure 1, with a reduction in DW (P: 0.001) and greater UF (P: 0.047). Table 1
A reduction in diastolic blood pressure was noted (P: 0.001)
In the control group, BLS did not change.

Conclusion

Our simplified LUS guided management protocol was able to safely reduce the pulmonary congestion in HD patients in addition to better controlling their blood pressure.